With 59 per cent of young Canadians backing federal IVF funding and no dollars in sight, employers remain the primary lever for family building coverage
Prime Minister Mark Carney’s 2026 budget was tabled without a single dollar allocated for in vitro fertilization (IVF).
According to Build Canada’s Outcomes Tracker, the words "fertility" and "IVF" don’t appear anywhere in its chapters, making it the third consecutive major federal fiscal document, after Budget 2025 and the April 2026 Spring Economic Update, to pass with no allocation for Ottawa's promised $20,000-per-patient fertility funding program.
Yet Fertility Matters Canada’s executive director Carolynn Dubé underscored how a federal program would remove the single largest financial barrier that employees face when pursuing fertility treatment. After all, the organization’s latest polling shows 49 per cent of Canadians who support a federal funding baseline.
IVF costs price employees out of treatment
“When you think about the average cost of someone who needs to access IVF, one round of IVF in Canada is about $20,000 paid upfront or paid out of pocket by the employee. In fact, a recent study through Fertility Alberta, which is a patient advocacy group in Alberta, found the average Albertan family spends about $35,000 out of pocket today to complete their treatment,” said Dubé, adding for many workers, particularly those early in their careers, the burden is high enough that they never reach a clinic at all.
“Employees have to choose between treatment and, lots of times, to be honest, their job," she added.
Heading into Budget 2026, Dubé said the organization had two demands: that Ottawa deliver on its campaign promise of $20,000 in IVF funding, and that insurers make fertility and family-building coverage a standard benefit rather than an add-on.
But with the budget now tabled and no funding in sight, she said the advocacy would continue.
Opt-in model creates fertility coverage gap
According to Dubé, one of the major disconnects she sees is in the way group insurance plans are structured. In most plans, fertility coverage is an add-on that an employer needs to request, she said, and most employers either don’t know it’s available or never think to ask. The opt-in model means the benefit sits dormant unless someone actively seeks it out.
Furthermore, a recent benefits report card the organization launched publicly graded 17 insurance companies on their fertility coverage. The core ask is that insurers flip the default, so employers can opt out of fertility coverage rather than opt in, “so that it takes the onus off the employer having to ask for it,” she said.
“The coverage is there from the get-go. With the federal or the government funding plus employer funding, coupled together can really help and will allow so many more Canadians to access the care that they need,” she added.
Employer plans can fill gaps public funding misses
As it currently stands, employer-sponsored benefits remain the primary lever for fertility coverage in Canada. Because of the repeated omissions for IVF in the budget, the organization is urging employers and insurers to bear the cost until the government takes notice.
“From the employee's perspective, it's invisible too because it's really hard for employees to disclose that this is something they're struggling with or going through. And it's really hard to talk about or advocate at work, especially if it’s an employer that doesn’t have those benefits,” said Dubé, underscoring it’s particularly challenging for women, who often need to signal pregnancy plans and an eventual maternity leave just to advocate for coverage.
Additionally, she acknowledged how many female employees feel that disclosure alone could hinder their advancement.
Young workers drive demand for fertility benefits
While the 49 per cent support figure was encouraging on its own, Dubé acknowledged, among Canadians aged 18 to 34, support for a federal funding baseline climbed to 59 per cent. This is the demographic most Canadian employers are competing to attract and retain in the first place, Dubé suggests.
“It should signal that there's huge support for this type of benefit and that in particular, young people are interested in that type of coverage," she said.
Additionally, according to Dubé, many publicly funded programs don’t cover fertility drugs, surrogacy, sperm donation, or genetic testing. If they do, they only cover a fraction of those costs.
That’s where employer-sponsored plans have the clearest opportunity to add value for employees who need coverage the public system doesn’t reach, said Dubé.
To that end, she pointed to survey data from the 2023 Carrot Fertility at Work report that underscored the talent attraction and retention case, noting 65 per cent of workers said they would change jobs for an employer that provided fertility benefits, while 42 per cent called a job offer without them a deal breaker.
On the retention side, 72 per cent said they would stay longer with an employer that offers fertility and family-building coverage.
“Offering these benefits really builds loyalty [with employers],” she said. “Having children is one of the most important aspects of so many people's lives. When employees are able to go through fertility treatment and take a baby home because they have an employer who had a robust fertility and family building benefits policy and plan in place, that’s significant.”


